Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Trends, Analysis, Growth, and Forecast: 2018 to 2027
MarketResearch.biz delivers in-depth insights on the global enzyme-linked immunosorbent assay (ELISA) testing market in its upcoming report titled, “Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global enzyme-linked immunosorbent assay (ELISA) testing market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global enzyme-linked immunosorbent assay (ELISA) testing market report has been segmented on the basis of test type, application, and region.
Enzyme-linked immunosorbent assay (ELISA) is a biochemical technique which is most commonly used to detect the presence of an antibody or antigen in a sample. The ELISA is a diagnostic tool which used in medicine, plant pathology and also has its applications in food industry. ELISA is quick and simple procedure to identify hormones, antibodies, proteins as well as peptides in biological samples. It is used in diagnosis of pregnancy tests, HIV infection and measurement of cytokines or soluble receptors in cell supernatant or serum.
Increasing number of cases of infectious diseases and cancer globally is expected to boost the growth of global enzyme-linked immunosorbent assay (ELISA) testing market over the forecast period. Continuous development of innovative and novel product by players in markets coupled with launched of this products is expected to boost the growth of market over the forecast period. Increasing demand for cost effective ELISA test for diagnosis for various diseases is expected to contribute to the market growth over the forecast period.
However, availability of alternate immunoassays test is a major factor expected to restraint the growth of the global enzyme-linked immunosorbent assay (ELISA) testing market over the forecast period.
North America market dominates the global enzyme-linked immunosorbent assay (ELISA) testing market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to presence of well-developed healthcare infrastructure and development & launch of innovative products in the region. Europe accounts for second-largest revenue share contribution to the global enzyme-linked immunosorbent assay (ELISA) testing market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to the developing healthcare infrastructure, presence of a large patient population, and increasing use of ELISA test as a diagnostic tool in the region.
Global Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Segmentation:
Global enzyme-linked immunosorbent assay (ELISA) testing market segmentation, by test type:
- Direct ELISA
- Indirect ELISA
- Sandwich ELISA
- Competitive ELISA
Global enzyme-linked immunosorbent assay (ELISA) testing market segmentation, by application:
- Vaccine Development
- Drug Monitoring & Pharmaceutical Industry
Global enzyme-linked immunosorbent assay (ELISA) testing market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- BioLegand, Inc.
- Enzo Life Sciences, Inc.
- Zeus Scientific, Inc.
- Shenzen YHLO Biotech Co. Ltd.
- Ortho-Clinical Diagnostics, Inc.
- R & D Systems Inc.
- BD Biosciences
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!